Skip to main content
Erschienen in: Inflammation 3/2014

01.06.2014

Immune Stimulation by Exogenous Melatonin During Experimental Endotoxemia

verfasst von: Katharina Effenberger-Neidnicht, Lisa Brencher, Martina Broecker-Preuss, Tim Hamburger, Frank Petrat, Herbert de Groot

Erschienen in: Inflammation | Ausgabe 3/2014

Einloggen, um Zugang zu erhalten

Abstract

Melatonin has been shown to enhance the immune response under immune-compromised conditions. However, its immune-modulatory effects under inflammatory conditions are unclear at present. Both pro- and anti-inflammation has been reported. To study time-dependent effects of melatonin on the general immune response during endotoxemia in more detail, we used two models in male rats: per-acute endotoxemia was induced by lipopolysaccharide (LPS) bolus injection (2.5 mg/kg), sub-acute endotoxemia by LPS infusion (2.5 mg/kg × h). Melatonin was applied directly before and 2 h after LPS administration (3 mg/kg, each). The LPS-induced formation of the pro-inflammatory cytokines tumor necrosis factor alpha, interferon-gamma, interleukin (IL)-1α/β, IL-5, and IL-6 and of the anti-inflammatory cytokine IL-10 was further amplified by melatonin, although it was only significant during per-acute endotoxemia. In both models, melatonin had no effect on the LPS-induced nitric oxide release. These findings show that exogenous melatonin is capable of enhancing the general immune response under inflammatory conditions.
Literatur
1.
Zurück zum Zitat Bone, R. 1991. Gram-negative sepsis. Background, clinical features, and intervention. Chest 100: 802–808.PubMedCrossRef Bone, R. 1991. Gram-negative sepsis. Background, clinical features, and intervention. Chest 100: 802–808.PubMedCrossRef
2.
Zurück zum Zitat Trampuz, A., and W. Zimmerli. 2003. Pathogenesis und Therapie der Sepsis. Schweiz Medical Forum 35: 811–818. Trampuz, A., and W. Zimmerli. 2003. Pathogenesis und Therapie der Sepsis. Schweiz Medical Forum 35: 811–818.
3.
Zurück zum Zitat Vincent, J.L., E.C. Serrano, and A. Dimoula. 2011. Current management of sepsis in critically ill adult patients. Expert Review of Anti-Infective Therapy 9: 847–856.PubMedCrossRef Vincent, J.L., E.C. Serrano, and A. Dimoula. 2011. Current management of sepsis in critically ill adult patients. Expert Review of Anti-Infective Therapy 9: 847–856.PubMedCrossRef
4.
Zurück zum Zitat Poli-de-Figueiredo, L.F., A.G. Garrido, N. Nakagawa, and P. Sannomiya. 2008. Experimental models of sepsis and their clinical relevance. Shock 30(Suppl 1): 53–59.PubMedCrossRef Poli-de-Figueiredo, L.F., A.G. Garrido, N. Nakagawa, and P. Sannomiya. 2008. Experimental models of sepsis and their clinical relevance. Shock 30(Suppl 1): 53–59.PubMedCrossRef
5.
Zurück zum Zitat Remick, D.G., and P.A. Ward. 2005. Evaluation of endotoxin models for the study of sepsis. Shock 24: 7–11.PubMedCrossRef Remick, D.G., and P.A. Ward. 2005. Evaluation of endotoxin models for the study of sepsis. Shock 24: 7–11.PubMedCrossRef
6.
Zurück zum Zitat Guardiola-Lemaitre, B. 1997. Toxicity of melatonin. Journal of Biological Rhythms 12: 697–706.PubMedCrossRef Guardiola-Lemaitre, B. 1997. Toxicity of melatonin. Journal of Biological Rhythms 12: 697–706.PubMedCrossRef
7.
Zurück zum Zitat Challet, E. 2007. Minireview: entrainment of the suprachiasmatic clockwork in diurnal and nocturnal mammals. Endocrinology 148: 5648–5655.PubMedCrossRef Challet, E. 2007. Minireview: entrainment of the suprachiasmatic clockwork in diurnal and nocturnal mammals. Endocrinology 148: 5648–5655.PubMedCrossRef
8.
Zurück zum Zitat Luchetti, F., B. Canonico, M. Betti, et al. 2010. Melatonin signaling and cell protection function. FASEB Journal 24: 3603–3624.PubMedCrossRef Luchetti, F., B. Canonico, M. Betti, et al. 2010. Melatonin signaling and cell protection function. FASEB Journal 24: 3603–3624.PubMedCrossRef
9.
Zurück zum Zitat Tan, D.X., L.C. Manchester, R. Hardeland, et al. 2003. Melatonin: a hormone, a tissue factor, an autocoid, a paracoid, and an antioxidant vitamin. Journal of Pineal Research 34: 75–78.PubMedCrossRef Tan, D.X., L.C. Manchester, R. Hardeland, et al. 2003. Melatonin: a hormone, a tissue factor, an autocoid, a paracoid, and an antioxidant vitamin. Journal of Pineal Research 34: 75–78.PubMedCrossRef
10.
Zurück zum Zitat Reiter, R.J., D.-X. Tan, L.C. Manchester, et al. 2007. Medical implication of melatonin: receptor-mediated and receptor-independent actions. Advanced Medical Science 52: 11–28. Reiter, R.J., D.-X. Tan, L.C. Manchester, et al. 2007. Medical implication of melatonin: receptor-mediated and receptor-independent actions. Advanced Medical Science 52: 11–28.
11.
Zurück zum Zitat Tan, D.X., L.D. Chen, B. Poeggeler, et al. 1993. Melatonin: a potent endogenous hydroxyl radical scavenger. Endocrine Journal 1: 57–60. Tan, D.X., L.D. Chen, B. Poeggeler, et al. 1993. Melatonin: a potent endogenous hydroxyl radical scavenger. Endocrine Journal 1: 57–60.
12.
Zurück zum Zitat Genade, S., A. Genis, K. Ytrehus, et al. 2008. Melatonin receptor-mediated protection against myocardial ischaemia/reperfusion injury: role of its anti-adrenergic actions. Journal of Pineal Research 45: 449–458.PubMedCrossRef Genade, S., A. Genis, K. Ytrehus, et al. 2008. Melatonin receptor-mediated protection against myocardial ischaemia/reperfusion injury: role of its anti-adrenergic actions. Journal of Pineal Research 45: 449–458.PubMedCrossRef
13.
Zurück zum Zitat Jockers, R., P. Maurice, J.A. Boutin, and P. Delagrange. 2008. Melatonin receptors, heterodimerization, signal transduction and binding sites: what’s new? British Journal of Pharmacology 154: 1182–1195.PubMedCentralPubMedCrossRef Jockers, R., P. Maurice, J.A. Boutin, and P. Delagrange. 2008. Melatonin receptors, heterodimerization, signal transduction and binding sites: what’s new? British Journal of Pharmacology 154: 1182–1195.PubMedCentralPubMedCrossRef
14.
Zurück zum Zitat Krause, D.N. 1991. Melatonin receptors. Annual Review of Pharmacology and Toxicology 31: 549–568.PubMedCrossRef Krause, D.N. 1991. Melatonin receptors. Annual Review of Pharmacology and Toxicology 31: 549–568.PubMedCrossRef
15.
Zurück zum Zitat Carrillo-Vico, A., P.J. Lardone, N. Alvarez-Sanchez, et al. 2013. Melatonin: buffering the immune system. International Journal of Molecular Sciences 14: 8638–8683.PubMedCentralPubMedCrossRef Carrillo-Vico, A., P.J. Lardone, N. Alvarez-Sanchez, et al. 2013. Melatonin: buffering the immune system. International Journal of Molecular Sciences 14: 8638–8683.PubMedCentralPubMedCrossRef
16.
Zurück zum Zitat Tian, Y.M., G.Y. Zhang, and Y.R. Dai. 2003. Melatonin rejuvenates degenerated thymus and redresses peripheral immune functions in aged mice. Immunology Letters 88: 101–104.PubMedCrossRef Tian, Y.M., G.Y. Zhang, and Y.R. Dai. 2003. Melatonin rejuvenates degenerated thymus and redresses peripheral immune functions in aged mice. Immunology Letters 88: 101–104.PubMedCrossRef
17.
Zurück zum Zitat Akbulut, K.G., B. Gönül, and H. Akbulut. 2001. The effects of melatonin on humoral immune responses of young and aged rats. Immunological Investigations 30: 17–20.PubMedCrossRef Akbulut, K.G., B. Gönül, and H. Akbulut. 2001. The effects of melatonin on humoral immune responses of young and aged rats. Immunological Investigations 30: 17–20.PubMedCrossRef
18.
Zurück zum Zitat Maestroni, G.J., A. Conti, and W. Pierpaoli. 1986. Role of the pineal gland in immunity. Circadian synthesis and release of melatonin modulates the antibody response and antagonizes the immunosuppressive effect of corticosterone. Journal of Neuroimmunology 13: 19–30.PubMedCrossRef Maestroni, G.J., A. Conti, and W. Pierpaoli. 1986. Role of the pineal gland in immunity. Circadian synthesis and release of melatonin modulates the antibody response and antagonizes the immunosuppressive effect of corticosterone. Journal of Neuroimmunology 13: 19–30.PubMedCrossRef
19.
Zurück zum Zitat Haldar, C., S. Rai, and R. Singh. 2004. Melatonin blocks dexamethasone-induced immunosuppression in a seasonally breeding rodent Indian palm squirrel, Funambulus pennan. Steroids 69: 367–377.PubMedCrossRef Haldar, C., S. Rai, and R. Singh. 2004. Melatonin blocks dexamethasone-induced immunosuppression in a seasonally breeding rodent Indian palm squirrel, Funambulus pennan. Steroids 69: 367–377.PubMedCrossRef
20.
Zurück zum Zitat Miller, S.C., P.S.R. Pandi, A.I. Esquifino, et al. 2006. The role of melatonin in immuno-enhancement: potential application in cancer. International Journal of Experimental Pathology 87: 81–87.PubMedCentralPubMedCrossRef Miller, S.C., P.S.R. Pandi, A.I. Esquifino, et al. 2006. The role of melatonin in immuno-enhancement: potential application in cancer. International Journal of Experimental Pathology 87: 81–87.PubMedCentralPubMedCrossRef
21.
Zurück zum Zitat Srinivasan, V., S.R. Pandi-Perumal, A. Brzezinski, et al. 2011. Melatonin, immune function and cancer. Recent Patent Endocrine Metabolic Immune Drug Discoveries 5: 109–123.CrossRef Srinivasan, V., S.R. Pandi-Perumal, A. Brzezinski, et al. 2011. Melatonin, immune function and cancer. Recent Patent Endocrine Metabolic Immune Drug Discoveries 5: 109–123.CrossRef
22.
Zurück zum Zitat Regodon, S., P. Martin-Palomino, R. Fernandez-Montesinos, et al. 2005. The use of melatonin as a vaccine agent. Vaccine 23: 5321–5327.PubMedCrossRef Regodon, S., P. Martin-Palomino, R. Fernandez-Montesinos, et al. 2005. The use of melatonin as a vaccine agent. Vaccine 23: 5321–5327.PubMedCrossRef
23.
Zurück zum Zitat Regodon, S., M. Del Prado Miguez, I. Jardin, et al. 2009. Melatonin, as an adjuvant-like agent, enhances platelet responsiveness. Journal of Pineal Research 46: 275–285.PubMedCrossRef Regodon, S., M. Del Prado Miguez, I. Jardin, et al. 2009. Melatonin, as an adjuvant-like agent, enhances platelet responsiveness. Journal of Pineal Research 46: 275–285.PubMedCrossRef
24.
Zurück zum Zitat Shang, Y., S.-P. Xu, Y. Wu, et al. 2009. Melatonin reduces acute lung injury in endotoxemic rats. Chinese Medical Journal 122: 1388–1393.PubMed Shang, Y., S.-P. Xu, Y. Wu, et al. 2009. Melatonin reduces acute lung injury in endotoxemic rats. Chinese Medical Journal 122: 1388–1393.PubMed
25.
Zurück zum Zitat Wu, C.-C., C.-W. Chiao, G. Hsiao, et al. 2001. Melatonin prevents endotoxin-induced circulatory failure in rats. Journal of Pineal Research 30: 147–156.PubMedCrossRef Wu, C.-C., C.-W. Chiao, G. Hsiao, et al. 2001. Melatonin prevents endotoxin-induced circulatory failure in rats. Journal of Pineal Research 30: 147–156.PubMedCrossRef
26.
Zurück zum Zitat Lowes, D.A., N.R. Webster, M.P. Murphy, and H.F. Galley. 2013. Antioxidants that protect mitochondria reduce interleukin-6 and oxidative stress, improve mitochondrial function, and reduce biochemical markers of organ dysfunction in a rat model of acute sepsis. British Journal of Anaesthesia 110: 472–480.PubMedCentralPubMedCrossRef Lowes, D.A., N.R. Webster, M.P. Murphy, and H.F. Galley. 2013. Antioxidants that protect mitochondria reduce interleukin-6 and oxidative stress, improve mitochondrial function, and reduce biochemical markers of organ dysfunction in a rat model of acute sepsis. British Journal of Anaesthesia 110: 472–480.PubMedCentralPubMedCrossRef
27.
28.
Zurück zum Zitat Bitzer-Quintero, O.K., G.G. Ortiz, L. Ruiz-Rizo, et al. 2005. Effects of melatonin on plasma levels of TNFa, IL-1 and IL-6 in mice after lipopolysaccharide administration. Biological Rhythm Research 36: 159–168.CrossRef Bitzer-Quintero, O.K., G.G. Ortiz, L. Ruiz-Rizo, et al. 2005. Effects of melatonin on plasma levels of TNFa, IL-1 and IL-6 in mice after lipopolysaccharide administration. Biological Rhythm Research 36: 159–168.CrossRef
29.
Zurück zum Zitat Del Angel-Meza, A.R., A.J. Davalos-Marin, L.L. Ontiveros-Martinez, et al. 2011. Protective effects of tryptophan on neuro-inflammation in rats after administering lipopolysaccharide. Biomedicine and Pharmacotherapy 65: 215–219.PubMedCrossRef Del Angel-Meza, A.R., A.J. Davalos-Marin, L.L. Ontiveros-Martinez, et al. 2011. Protective effects of tryptophan on neuro-inflammation in rats after administering lipopolysaccharide. Biomedicine and Pharmacotherapy 65: 215–219.PubMedCrossRef
30.
Zurück zum Zitat Carrillo-Vico, A., P.J. Lardone, L. Naji, et al. 2005. Beneficial pleiotropic actions of melatonin in an experimental model of septic shock in mice: regulation of pro-/anti-inflammatory cytokine network, protection against oxidative damage and anti-apoptotic effects. Journal of Pineal Research 39: 400–408.PubMedCrossRef Carrillo-Vico, A., P.J. Lardone, L. Naji, et al. 2005. Beneficial pleiotropic actions of melatonin in an experimental model of septic shock in mice: regulation of pro-/anti-inflammatory cytokine network, protection against oxidative damage and anti-apoptotic effects. Journal of Pineal Research 39: 400–408.PubMedCrossRef
31.
Zurück zum Zitat Zhong, L.-Y., Z.-H. Yang, X.-R. Li, et al. 2009. Protective effects of melatonin against the damages of neuroendocrine-immune induced by lipopolysaccharide in diabetic rats. Experimental and Clinical Endocrinology and Diabetes 117: 463–469.PubMedCrossRef Zhong, L.-Y., Z.-H. Yang, X.-R. Li, et al. 2009. Protective effects of melatonin against the damages of neuroendocrine-immune induced by lipopolysaccharide in diabetic rats. Experimental and Clinical Endocrinology and Diabetes 117: 463–469.PubMedCrossRef
32.
Zurück zum Zitat Sacco, S., L. Aquilini, P. Ghezzi, et al. 1998. Mechanism of the inhibitory effect of melatonin on tumor necrosis factor production in vivo and in vitro. E J Pharmacology 343: 249–255.CrossRef Sacco, S., L. Aquilini, P. Ghezzi, et al. 1998. Mechanism of the inhibitory effect of melatonin on tumor necrosis factor production in vivo and in vitro. E J Pharmacology 343: 249–255.CrossRef
33.
Zurück zum Zitat Maestroni, G.J. 1996. Melatonin as a therapeutic agent in experimental endotoxic shock. Journal of Pineal Research 20: 84–89.PubMedCrossRef Maestroni, G.J. 1996. Melatonin as a therapeutic agent in experimental endotoxic shock. Journal of Pineal Research 20: 84–89.PubMedCrossRef
34.
Zurück zum Zitat Tyagi, E., R. Agrawal, C. Nath, and R. Shukla. 2010. Effect of melatonin on neuroinflammation and acetylcholinesterase activity induced by LPS in rat brain. European Journal of Pharmacology 640: 206–210.PubMedCrossRef Tyagi, E., R. Agrawal, C. Nath, and R. Shukla. 2010. Effect of melatonin on neuroinflammation and acetylcholinesterase activity induced by LPS in rat brain. European Journal of Pharmacology 640: 206–210.PubMedCrossRef
35.
Zurück zum Zitat Wang, H., W. Wei, Y.-X. Shen, et al. 2004. Protective effect of melatonin against liver injury in mice induced by Bacillus Calmette-Guerin plus lipopolysaccharide. World Journal of Gastroenterology 10: 2690–2696.PubMed Wang, H., W. Wei, Y.-X. Shen, et al. 2004. Protective effect of melatonin against liver injury in mice induced by Bacillus Calmette-Guerin plus lipopolysaccharide. World Journal of Gastroenterology 10: 2690–2696.PubMed
36.
Zurück zum Zitat Yavuz, T., D. Kaya, M. Behcet, et al. 2007. Effects of melatonin on Candida sepsis in an experimental rat model. Advances in Therapy 24: 91–100.PubMedCrossRef Yavuz, T., D. Kaya, M. Behcet, et al. 2007. Effects of melatonin on Candida sepsis in an experimental rat model. Advances in Therapy 24: 91–100.PubMedCrossRef
37.
Zurück zum Zitat Wu, J.-Y., M.-Y. Tsou, T.-H. Chen, et al. 2008. Therapeutic effects of melatonin on peritonitis-induced septic shock with multiple organ dysfunction syndrome in rats. Journal of Pineal Research 45: 106–116.PubMedCrossRef Wu, J.-Y., M.-Y. Tsou, T.-H. Chen, et al. 2008. Therapeutic effects of melatonin on peritonitis-induced septic shock with multiple organ dysfunction syndrome in rats. Journal of Pineal Research 45: 106–116.PubMedCrossRef
38.
Zurück zum Zitat Petrat, F., J. Drowatzky, K. Boengler, et al. 2011. Protection from glycine at low doses in ischemia-reperfusion injury of the rat small intestine. European Surgical Research 46: 180–187.PubMedCrossRef Petrat, F., J. Drowatzky, K. Boengler, et al. 2011. Protection from glycine at low doses in ischemia-reperfusion injury of the rat small intestine. European Surgical Research 46: 180–187.PubMedCrossRef
39.
Zurück zum Zitat Effenberger-Neidnicht, K., M. Al Nator, L. Brencher, et al. 2013. Prevention of endotoxin-induced hypotension in rats by the circadian hormone melatonin. Infection 41: S11–S12. Effenberger-Neidnicht, K., M. Al Nator, L. Brencher, et al. 2013. Prevention of endotoxin-induced hypotension in rats by the circadian hormone melatonin. Infection 41: S11–S12.
40.
Zurück zum Zitat Hamburger, T., M. Broecker-Preuss, M. Hartmann, et al. 2013. Effects of glycine, pyruvate, resveratrol, and nitrite on tissue injury and cytokine response in endotoxemic rats. Journal of Surgical Research 183: e7–e21.PubMedCrossRef Hamburger, T., M. Broecker-Preuss, M. Hartmann, et al. 2013. Effects of glycine, pyruvate, resveratrol, and nitrite on tissue injury and cytokine response in endotoxemic rats. Journal of Surgical Research 183: e7–e21.PubMedCrossRef
41.
Zurück zum Zitat Di, W.-L., A. Kadva, O. Djahanbakhch, and R. Silman. 1998. Radioimmunoassay of bound and free melatonin in plasma. Clinical Chemistry 44: 304–310.PubMed Di, W.-L., A. Kadva, O. Djahanbakhch, and R. Silman. 1998. Radioimmunoassay of bound and free melatonin in plasma. Clinical Chemistry 44: 304–310.PubMed
43.
Zurück zum Zitat Jean-Baptiste, E. 2007. Cellular mechanisms in sepsis. Journal of Intensive Care Medicine 22: 63–72.PubMedCrossRef Jean-Baptiste, E. 2007. Cellular mechanisms in sepsis. Journal of Intensive Care Medicine 22: 63–72.PubMedCrossRef
44.
Zurück zum Zitat Dinarello, C.A. 1997. Pro-inflammatory and anti-inflammatory cytokines as mediators in the pathogenesis of septic shock. Chest 112: 321S–329S.PubMedCrossRef Dinarello, C.A. 1997. Pro-inflammatory and anti-inflammatory cytokines as mediators in the pathogenesis of septic shock. Chest 112: 321S–329S.PubMedCrossRef
45.
Zurück zum Zitat Green, L.C., D.A. Wagner, and J. Glogowski. 1982. Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids. Analytical Biochemistry 126: 131–138.PubMedCrossRef Green, L.C., D.A. Wagner, and J. Glogowski. 1982. Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids. Analytical Biochemistry 126: 131–138.PubMedCrossRef
46.
Zurück zum Zitat Habbal, O.A., and A.A. Al-Jabri. 2009. Circadian rhythm and the immune response: a review. International Reviews of Immunology 28: 93–108.PubMedCrossRef Habbal, O.A., and A.A. Al-Jabri. 2009. Circadian rhythm and the immune response: a review. International Reviews of Immunology 28: 93–108.PubMedCrossRef
47.
Zurück zum Zitat Vgontzas, A.N., D.A. Papanicolaou, E.O. Bixler, et al. 1999. Circadian interleukin-6 secretion and quantity and depth of sleep. Endocrinology and Metabolism 84: 2603–2607.CrossRef Vgontzas, A.N., D.A. Papanicolaou, E.O. Bixler, et al. 1999. Circadian interleukin-6 secretion and quantity and depth of sleep. Endocrinology and Metabolism 84: 2603–2607.CrossRef
48.
Zurück zum Zitat Dominguez-Rodriguez, A., P. Abreu-Gonzalez, M. Garcia, et al. 2004. Light/dark patterns of interleukin-6 in relation to the pineal hormone melatonin in patients with acute myocardial infarction. Cytokine 26: 89–93.PubMedCrossRef Dominguez-Rodriguez, A., P. Abreu-Gonzalez, M. Garcia, et al. 2004. Light/dark patterns of interleukin-6 in relation to the pineal hormone melatonin in patients with acute myocardial infarction. Cytokine 26: 89–93.PubMedCrossRef
49.
Zurück zum Zitat Oliveira, L.G., C.C. Kuehn, C.D. Santos, et al. 2010. Enhanced protection by melatonin and meloxicam combination in experimental infection by Trypanosoma cruzi. Parasite Immunology 32: 245–251.PubMedCrossRef Oliveira, L.G., C.C. Kuehn, C.D. Santos, et al. 2010. Enhanced protection by melatonin and meloxicam combination in experimental infection by Trypanosoma cruzi. Parasite Immunology 32: 245–251.PubMedCrossRef
50.
Zurück zum Zitat Valero, N., E. Bonilla, H. Pons, et al. 2002. Melatonin induces changes to serum cytokines in mice infected with the Venezuelan equine encephalomyelitis virus. Transactions of the Royal Society of Tropical Medicine and Hygiene 96: 348–351.PubMedCrossRef Valero, N., E. Bonilla, H. Pons, et al. 2002. Melatonin induces changes to serum cytokines in mice infected with the Venezuelan equine encephalomyelitis virus. Transactions of the Royal Society of Tropical Medicine and Hygiene 96: 348–351.PubMedCrossRef
51.
Zurück zum Zitat Arias, J., E. Melean, N. Valero, et al. 2003. Effect of melatonin on lymphocyte proliferation and production of interleukin-2 (il-2) and interleukin-1 beta (il-1 beta) in mice splenocytes. Investigación Clínica 44: 41–50.PubMed Arias, J., E. Melean, N. Valero, et al. 2003. Effect of melatonin on lymphocyte proliferation and production of interleukin-2 (il-2) and interleukin-1 beta (il-1 beta) in mice splenocytes. Investigación Clínica 44: 41–50.PubMed
52.
Zurück zum Zitat Currier, N.L., L.Z. Sun, and S.C. Miller. 2000. Exogenous melatonin: quantitative enhancement in vivo of cells mediating non-specific immunity. Journal of Neuroimmunology 104: 101–108.PubMedCrossRef Currier, N.L., L.Z. Sun, and S.C. Miller. 2000. Exogenous melatonin: quantitative enhancement in vivo of cells mediating non-specific immunity. Journal of Neuroimmunology 104: 101–108.PubMedCrossRef
53.
Zurück zum Zitat Maestroni, G.J. 2001. The immunotherapeutic potential of melatonin. Experimental Opinion Investigative Drugs 10: 467–476.CrossRef Maestroni, G.J. 2001. The immunotherapeutic potential of melatonin. Experimental Opinion Investigative Drugs 10: 467–476.CrossRef
54.
Zurück zum Zitat Maestroni, G.J. 1995. T-helper-2 lymphocytes as a peripheral target of melatonin. Journal of Pineal Research 18: 84–89.PubMedCrossRef Maestroni, G.J. 1995. T-helper-2 lymphocytes as a peripheral target of melatonin. Journal of Pineal Research 18: 84–89.PubMedCrossRef
55.
Zurück zum Zitat Carrillo-Vico, A., A. Garcia-Perganeda, L. Naji, et al. 2003. Expression of membrane and nuclear melatonin receptor mRNA and protein in the mouse immune system. Cellular and Molecular Life Sciences 60: 2272–2278.PubMedCrossRef Carrillo-Vico, A., A. Garcia-Perganeda, L. Naji, et al. 2003. Expression of membrane and nuclear melatonin receptor mRNA and protein in the mouse immune system. Cellular and Molecular Life Sciences 60: 2272–2278.PubMedCrossRef
56.
Zurück zum Zitat Drazen, D.L., and R.J. Nelson. 2001. Melatonin receptor subtype MT2 (Mel 1b) and not mt1 (Mel 1a) is associated with melatonin-induced enhancement of cell-mediated and humoral immunity. Neuroendocrinology 74: 178–184.PubMedCrossRef Drazen, D.L., and R.J. Nelson. 2001. Melatonin receptor subtype MT2 (Mel 1b) and not mt1 (Mel 1a) is associated with melatonin-induced enhancement of cell-mediated and humoral immunity. Neuroendocrinology 74: 178–184.PubMedCrossRef
57.
Zurück zum Zitat Kidd, P. 2003. Th1/Th2 balance: the hypothesis, its limitations, and implications for health and disease. Alternative Medicine Review 8: 223–246.PubMed Kidd, P. 2003. Th1/Th2 balance: the hypothesis, its limitations, and implications for health and disease. Alternative Medicine Review 8: 223–246.PubMed
58.
59.
Zurück zum Zitat Xing, Z., J. Gauldie, G. Cox, et al. 1998. IL-6 is an antiinflammatory cytokine required for controlling local or systemic acute inflammatory responses. Journal of Clinical Investigation 101: 311–320.PubMedCentralPubMedCrossRef Xing, Z., J. Gauldie, G. Cox, et al. 1998. IL-6 is an antiinflammatory cytokine required for controlling local or systemic acute inflammatory responses. Journal of Clinical Investigation 101: 311–320.PubMedCentralPubMedCrossRef
60.
Zurück zum Zitat Loddick, S.A., A.V. Turnbull, and N.J. TRothwell. 1998. Cerebral interleukin-6 is protective during permanent focal cerebral ischemia in the rat. Journal of Cerebral Blood Flow and Metabolism 18: 176–179.PubMedCrossRef Loddick, S.A., A.V. Turnbull, and N.J. TRothwell. 1998. Cerebral interleukin-6 is protective during permanent focal cerebral ischemia in the rat. Journal of Cerebral Blood Flow and Metabolism 18: 176–179.PubMedCrossRef
61.
Zurück zum Zitat Toulmond, S., X. Vige, D. Fage, and J. Benavides. 1992. Local infusion of interleukin-6 attenuates the neurotoxic effects of NMDA on rat striatal cholinergic neurons. Neuroscience Letters 144: 49–52.PubMedCrossRef Toulmond, S., X. Vige, D. Fage, and J. Benavides. 1992. Local infusion of interleukin-6 attenuates the neurotoxic effects of NMDA on rat striatal cholinergic neurons. Neuroscience Letters 144: 49–52.PubMedCrossRef
62.
Zurück zum Zitat Xu, L.L., A. Kitani, I. Fuss, and W. Strober. 2007. Cutting edge: regulatory T cells induce CD4+CD25-Foxp3- T cells or are self-induced to become TH17 cells in the absence of exogenous TGF-b. Journal of Immunology 178: 6725–6729.CrossRef Xu, L.L., A. Kitani, I. Fuss, and W. Strober. 2007. Cutting edge: regulatory T cells induce CD4+CD25-Foxp3- T cells or are self-induced to become TH17 cells in the absence of exogenous TGF-b. Journal of Immunology 178: 6725–6729.CrossRef
63.
Zurück zum Zitat Bettelli, E., Y. Carrier, W. Gao, et al. 2006. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 441: 235–238.PubMedCrossRef Bettelli, E., Y. Carrier, W. Gao, et al. 2006. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 441: 235–238.PubMedCrossRef
64.
Zurück zum Zitat Wang, T.S., and J.C. Deng. 2008. Molecular and cellular aspects of sepsis-induced immunosuppression. Journal of Molecular Medicine (Berl) 86: 495–506.CrossRef Wang, T.S., and J.C. Deng. 2008. Molecular and cellular aspects of sepsis-induced immunosuppression. Journal of Molecular Medicine (Berl) 86: 495–506.CrossRef
65.
Zurück zum Zitat Benjamim, C.F., C.M. Hogaboam, and S.L. Kunkel. 2004. The chronic consequences of severe sepsis. Journal of Leukocyte Biology 75: 408–412.PubMedCrossRef Benjamim, C.F., C.M. Hogaboam, and S.L. Kunkel. 2004. The chronic consequences of severe sepsis. Journal of Leukocyte Biology 75: 408–412.PubMedCrossRef
66.
Zurück zum Zitat Li, C.X., D.D. Liang, G.H. Xie, et al. 2013. Altered melatonin secretion and circadian gene expression with increased proinflammatory cytokine expression in early-stage sepsis patients. Molecular Medicine Reports 7: 1117–1122.PubMed Li, C.X., D.D. Liang, G.H. Xie, et al. 2013. Altered melatonin secretion and circadian gene expression with increased proinflammatory cytokine expression in early-stage sepsis patients. Molecular Medicine Reports 7: 1117–1122.PubMed
67.
Zurück zum Zitat Pinheiro da Silva F, Cesar Machado MC, Sallet PC et al. Neuropeptide downregulation in sepsis. Inflammation 2013 (in press). Pinheiro da Silva F, Cesar Machado MC, Sallet PC et al. Neuropeptide downregulation in sepsis. Inflammation 2013 (in press).
Metadaten
Titel
Immune Stimulation by Exogenous Melatonin During Experimental Endotoxemia
verfasst von
Katharina Effenberger-Neidnicht
Lisa Brencher
Martina Broecker-Preuss
Tim Hamburger
Frank Petrat
Herbert de Groot
Publikationsdatum
01.06.2014
Verlag
Springer US
Erschienen in
Inflammation / Ausgabe 3/2014
Print ISSN: 0360-3997
Elektronische ISSN: 1573-2576
DOI
https://doi.org/10.1007/s10753-013-9792-y

Weitere Artikel der Ausgabe 3/2014

Inflammation 3/2014 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.